Intraday Trading Solution👍
رفتن به کانال در Telegram
This channel is truly for educational purposes. And If you earn profits from our levels . NSE REGISTERED AP . Contact Your Financial Advisor Before Taking Trades. #NIFTY #BANKNIFTY #CRUDEOIL #INTRADAY #STOCKS # SHARE MARKET
نمایش بیشتر6 532
مشترکین
-424 ساعت
-667 روز
-21530 روز
آرشیو پست ها
95 to 108🔥13 points done ✅ enjoy guys keep booking profit on target 🎯Qty 150× 13= 1950rs./Lot done
✅INTRADAY+SWING✅
BUY HAL JUNE 5100CE
AROUND 95-114 TRG 118/125/135
wait for activation near Entry point
3️⃣ SENSEX – Closed at 81,118
🟠 Consolidation Mode
Support: 80,900 / 80,360
Resistance: 81,500 / 82,100
RSI: 49 – sideways bias
📌 Trapped in a tight range; wait for either 81.5K breakout or 80.9K breakdown.
Technical view of Banknifty
2️⃣ BANK NIFTY – Closed at 55,527
🔴 Weaker than Nifty
Support: 55,100 / 54,800
Resistance: 55,700 / 56,000
High call OI @ 55,500
Below 55,100 = bearish
Above 55,700 = recovery begins
📌 Avoid aggressive longs unless breakout.
Technical view of NIFTY 5
1️⃣ NIFTY 50 – Closed at 24,718
🟡 Rangebound but vulnerable
Support: 24,650 / 24,450
Resistance: 24,850 / 25,200
RSI: 51 – neutral
Below 24,450 = more downside
Above 24,900 = breakout chance
📌 Wait for a directional move.
STOCKS IN THE WATCH
1. Sun Pharma (NSE: SUNPHARMA)
News: FDA issued Form-483 with 8 observations at Halol plant (negative sentiment).
Current Price: ₹1,687.80
Entry: ₹1,650–1,660
Stop-loss: ₹1,610
Targets:
T1: ₹1,700 (gap-fill)
T2: ₹1,740 (previous swing high)
T3: ₹1,780 (if regulatory risk cools down)
2. Natco Pharma (NSE: NATCOPHARM)
News: Only 1 FDA observation at Mekaguda plant – minor impact.
Current Price: ₹912.70
Entry: ₹880–900
Stop-loss: ₹850
Targets:
T1: ₹940 (recent resistance)
T2: ₹980 (medium-term breakout)
T3: ₹1,020 (if sentiment improves further
3. Arkade Developers
News: Enters Thane market with ₹2,000 crore GDV project – bullish real estate trigger.
Current Price: ₹191.20
Entry: ₹185–190
Stop-loss: ₹178
Targets:
T1: ₹200
T2: ₹215
T3: ₹230 (if project launch traction is strong)
---
4. Birla Corporation (NSE: BIRLACORPN)
News: Wins mining lease for limestone block in Rajasthan – positive for long-term raw material security.
Current Price: [verify — approx ₹1,520]
Entry: ₹1,500–1,530
Stop-loss: ₹1,450
Targets:
T1: ₹1,580
T2: ₹1,640
T3: ₹1,700
---
5. Ireda (NSE: IREDA)
News: NCLT admitted ₹218.95 cr claim against Gensol EV Lease – positive step toward recovery.
Current Price: ₹167.26
Entry: ₹160–165
Stop-loss: ₹155
Targets:
T1: ₹175
T2: ₹185
T3: ₹195 (if resolution sees traction)
6. Capri Global (NSE: CGCL)
News: Successfully raised ₹2,000 cr via QIB – strong institutional backing.
Current Price: ₹171.13
Entry: ₹165–168
Stop-loss: ₹160
Targets:
T1: ₹178
T2: ₹185
T3: ₹195
STOCKS IN THE WATCH
Sun Pharma:The US health regulator has issued a form 483 with 8 observations after inspecting Sun Pharma's Halol (Gujarat) manufacturing plant.
Natco Pharma:The United States Food and Drugs Administration (US FDA) concluded its inspection of the company's Mekaguda plant with one observation in form-483.
Arkade Developers:The company has entered the Thane market with a 6.28 acre project with an estimated gross development value (GDV) of ₹ 2000 crore.
Birla Corporation: The company emerged as the 'Preferred Bidder’ for the grant of mining lease for Gourum Khan Ki Dhani (South) Limestone Block, on the highest final price offer of 20.60 per cent. The aforesaid block is situated in District Jaisalmer, Rajasthan over an area of 499.6394 hectares.
Ireda: The application filed by the company under Section 7 of the Insolvency and Bankruptcy Code, 2016 against Gensol EV Lease which is a subsidiary of Gensol Engineering was admitted by National Company Law Tribunal Ahmedabad (NCLT) for corporate insolvency resolution process. The amount due was ₹218.95 crore.
Capri Global:The company successfully raised ₹2,000 crore through the issuance of equity shares to Qualified Institutional Buyers.
